CellSource Co., Ltd. (TYO:4880)
Japan · Delayed Price · Currency is JPY 386.00
+6.00 (1.58%)
At close: Mar 6, 2026
CellSource Market Cap
CellSource has a market cap or net worth of 7.65 billion as of March 6, 2026. Its market cap has decreased by -55.39% in one year.
Market Cap
7.65B
Enterprise Value
3.00B
Revenue
3.71B
Ranking
n/a
PE Ratio
765.31
Stock Price
386.00
Market Cap Chart
Since October 29, 2019, CellSource's market cap has decreased from 13.48B to 7.65B, a decrease of -43.22%. That is a compound annual growth rate of -8.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 7.65B | -3.24% |
| Dec 30, 2025 | 7.91B | -52.01% |
| Dec 30, 2024 | 16.48B | -34.91% |
| Dec 29, 2023 | 25.32B | -66.16% |
| Dec 30, 2022 | 74.83B | -26.01% |
| Dec 30, 2021 | 101.14B | 51.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 29, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| StemCell Institute | 9.02B |
| MEDINET | 8.27B |
| BrightPath Biotherapeutics | 8.17B |
| OncoTherapy Science | 7.91B |
| ADR120S | 7.87B |
| PRISM BioLab Co.,LTD | 7.46B |
| Chiome Bioscience | 7.43B |
| Linical | 7.11B |